tirzepatide weight loss plateau advice How to Break a Time to weight plateau with

2024 Study Warns About GLP-1 Gastric Side Effects In the latest study, a group of researchers from Beijing University of Chinese Medicine and the University of Chicago performed a systemic review of 76 studies to evaluate the comparative safety and effectiveness of fifteen different GLP-1 receptor agonists, including semaglutide (Ozempic and Wegovy), tirzepatide (Mounjaro and Zepbound), exenatide (Byetta and Bydureon) and other commonly prescribed brands

The pivotal SURMOUNT and SURPASS trial programs primarily focused on weight loss and glycemic outcomes, with reproductive health not designated as a primary endpoint

Dispensed only pursuant to a valid prescription for an identified individual patient

Several factors explain this gap

Choose tirzepatide if: GI tolerance is a primary concern and you want lower nausea and vomiting rates